In the discussion, Petrylak highlighted advances in identifying genetic mutations and emerging strategies for early, ...

Former US President Joe Biden is undergoing a new treatment regimen for his aggressive form of prostate cancer, according to ...

Progress in cancer research, including approval of 20 new anticancer therapeutics in the past year, is described in the 15th edition of the AACR Cancer Progress Report.

Primary results from the Phase III evERA Breast Cancer study, the first positive head-to-head Phase III trial investigating an all-oral selective estrogen receptor (ER) degrader-containing regimen ...

As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, announces key ...

The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously ...

The five-year survival rate for a woman diagnosed with breast cancer has jumped up from around 75% in the early 1980s, to ...

A century ago, a breast cancer diagnosis came with a grim prognosis. The five-year survival rate for breast cancer in the U.S. during the 1920s was less than 5%. But thanks to decades of research and ...

Medical oncologist Dr. Pamela Drullinsky speaks with ABC News’ Linsey Davis about ways to detect breast cancer earlier and ...

20 new anticancer therapeutics, two new devices, two minimally invasive tests, AI-based tools for early detection approved by FDA. (HealthDay News) — Progress in cancer research, including approval of ...